PRZEGLĄD LITERATURY NA PODSTAWIE PRZYPADKÓW
Orbital pseudotumor and skull base infiltration as the sole manifestation of granulomatosis with polyangiitis
Więcej
Ukryj
1
Student Clinical Rheumatology Circle, Medical University of Gdansk, Poland
2
Central Hospital of Vaasa, Finland
3
Visby Lasarett, Visby, Sweden
4
Second Department of Radiology, Medical University of Gdansk, Poland
5
Department of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdansk, Poland
Data nadesłania: 23-07-2025
Data ostatniej rewizji: 25-01-2026
Data akceptacji: 23-03-2026
Data publikacji: 29-06-2026
Autor do korespondencji
Anna Masiak
Department of Rheumatology, Clinical Immunology, Geriatrics and Internal Medicine, Medical University of Gdańsk, Poland
Reumatologia 2026;64(3):242-251
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Granulomatosis with polyangiitis (GPA) is a vasculitis affecting small and medium-sized blood vessels. It typically presents with upper respiratory tract, lung, and kidney involvement. However, the disease may involve multiple other organs, and not all cases present with these classic manifestations. Periocular lesions are described in the GPA and, especially in the case of isolated, single-site disease, require extensive differentiation from other diseases, such as IgG4-related disease or myofibroblastic tumor. However, periocular lesions and coexisting symptoms suggesting changes in the central nervous system without other organ changes are undoubtedly a diagnostic challenge. Such situations are described in the literature mainly as case reports, not as a rule in connection with GPA. The impetus for writing this article and analyzing the literature was a case of GPA manifesting as infiltration of the skull base presenting as multiple cranial nerve palsies. A review of atypical cases of GPA in the literature suggests that skull-based involvement is an important yet easily overlooked presentation. Through this case-based review, we aim to raise awareness that GPA may present with isolated cranial nerve palsies.
REFERENCJE (31)
1.
Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 2013; 65: 1–11, DOI: 10.1002/art.37715.
2.
Kiessling PT, Marinelli JP, Peters PA, et al. Cranial base manifestations of granulomatosis with polyangiitis. Otolaryngol Head Neck Surg 2020; 162: 666–673, DOI: 10.1177/0194599820912025.
3.
Tarabishy AB, Schulte M, Papaliodis GN, Hoffman GS. Wegener’s granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol 2010; 55: 429–444, DOI: 10.1016/j.survophthal.2009.12.003.
4.
Masiak A, Zdrojewski Z, Pęksa R, et al. The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis. Reumatologia 2017; 55: 230–236, DOI: 10.5114/reum.2017.71638.
5.
Kronbichler A, Lee KH, Denicolo S, et al. Immunopathogenesis of ANCA‑Associated Vasculitis. Int J Mol Sci 2020; 21: 7319, DOI: 10.3390/ijms21197319.
6.
Roozendaal C, de Jong MA, van den Berg AP, et al. Clinical significance of anti‑neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. J Hepatol 2000; 32: 734–741. DOI: 10.1016/S0168-8278(00)00060-5.
7.
Terjung B, Spengler U, Sauerbruch T, Worman HJ. Atypical p‑ANCA in inflammatory bowel and hepatobiliary diseases: reactivity with a 50‑kDa nuclear envelope protein of neutrophils. Gastroenterology 2000; 119: 310–322, DOI: 10.1053/gast. 2000.9366.
8.
Muller K, Lin JH. Orbital granulomatosis with polyangiitis (Wegener granulomatosis): clinical and pathologic findings. Arch Pathol Lab Med 2014; 138: 1110–1114, DOI: 10.5858/ arpa.2013‑0006‑RS.
9.
Holle JU, Voigt C, Both M, et al. Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage. Rheumatology (Oxford) 2013; 52: 875–882, DOI: 10.1093/rheumatology/kes382.
10.
Sakai M, Hiyama T, Kuno H, et al. Imaging of the skull base and orbital tumors. Jpn J Radiol 2025; 43: 152–163, DOI: 10.1007/s11604-024-01662-9.
11.
Aygün D, Doğan C, Hepokur M, et al. Evaluation of patients with orbital infections. Turk Pediatri Ars 2017; 52: 221–225, DOI: 10.5152/TurkPediatriArs.2017.5511.
12.
Zayet S, Zaghdoudi A, Ammari L, et al. Cerebro-rhino-orbital mucormycosis and aspergillosis coinfection in a patient with diabetes mellitus: A case report. IDCases 2021; 23: e01022, DOI: 10.1016/j.idcr.2020.e01022.
13.
Bartalena L, Kahaly GJ, Baldeschi L, et al. The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy. Eur J Endocrinol 2021; 185: G43–G67, DOI: 10.1530/EJE-21-0479.
14.
Manish MG, Goswamy J, Solanki K, Bhalla R. Infiltrative mass of the skull base and nasopharynx: a diagnostic conundrum. Ann Med Surg (Lond) 2015; 4: 103–106, DOI: 10.1016/j.amsu. 2015.03.005.
15.
Abdullaeva U, Pape B, Hirvonen J. Diagnostic accuracy of MRI for orbital and intracranial invasion of sinonasal malignancies: a systematic review and meta-analysis. J Clin Med 2024; 13: 7556, DOI: 10.3390/jcm13247556.
16.
Chapman PR, Choudhary G, Singhal A. Skull base osteomyelitis: a comprehensive imaging review. AJNR Am J Neuroradiol 2021, DOI: 10.3174/ajnr.A7015.
17.
Salfrant M, Garcia GCTE, Guichard JP, et al. Imaging of skull base and orbital invasion in sinonasal cancer: correlation with histopathology. Cancers (Basel) 2021; 13: 4963, DOI: 10.3390/cancers13194963.
18.
Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993; 33: 4–9, DOI: 10.1002/ana.410330103.
19.
Wójcik K, Wawrzycka‑Adamczyk K, Włudarczyk A, et al. Clinical characteristics of Polish patients with ANCA‑associated vasculitides – retrospective analysis of POLVAS registry. Clin Rheumatol 2019; 38: 2553–2563, DOI: 10.1007/s10067‑019‑04538‑w.
20.
Bonek K, Brożek-Mądry E, Wroński J, et al. Combination treatment of locoregionally aggressive granulomatosis with polyangiitis and cranial base infiltration. Brain Sci 2023; 13: 1140, DOI: 10.3390/brainsci13081140.
21.
De Luna G, Terrier B, Kaminsky P, et al. Central nervous system involvement of granulomatosis with polyangiitis: clinical‑ radiological presentation distinguishes different outcomes. Rheumatology (Oxford) 2015; 54: 424–432. DOI: 10.1093/ rheumatology/keu336.
22.
De Groot K, Schmidt DK, Arlt AC, et al. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001; 58: 1215–1221, DOI: 10.1001/archneur. 58.8.1215.
23.
Wojciechowska J, Kręcicki T. Clinical characteristics of patients with granulomatosis with polyangiitis and microscopic polyangiitis in ENT practice: a comparative analysis. Acta Otorhinolaryngol Ital 2018; 38: 517–527, DOI: 10.14639/0392-100X-1776.
24.
Tsuzuki K, Fukazawa K, Takebayashi H, et al. Difficulty of diagnosing Wegener’s granulomatosis in the head and neck region. Auris Nasus Larynx 2009; 36: 64–70. DOI: 10.1016/ j.anl.2008.02.003.
25.
Marini K, Garefis K, Skliris JP, et al. Granulomatosis with polyangiitis: multiple cranial nerve manifestations and nasopharyngeal pseudotumor. Ear Nose Throat J 2024; 103: 470–472, DOI: 10.1177/01455613211069925.
26.
Horiuchi K, Oshima Y, Kudo A. Successful treatment with rituximab for granulomatosis with polyangiitis and multiple cranial neuropathies. Intern Med 2021; 60: 1095–1099, DOI: 10.2169/internalmedicine.4881-20.
27.
Daderian AD, Chayasirisobhon S. An unusual case of multiple cranial nerve palsies in Wegener’s granulomatosis. J Natl Med Assoc 2000; 92: 455–457, DOI: 10.1016/S0027-9684(15)- 31484-3.
28.
Batinović F, Krnić Martinić M, Glavina Durdov M, Sunara D. A case of unilateral otologic symptoms as initial manifestations of granulomatosis with polyangiitis. J Audiol Otol 2023; 27: 161–167, DOI: 10.7874/jao.2022.00311.
29.
Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002; 110: 955–963, DOI: 10.1172/JCI15918.
30.
Argyropoulou OD, Goules AV, Boutzios G, et al. Occurrence and antigenic specificity of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in systemic autoimmune diseases. Cells 2021; 10: 2128, DOI: 10.3390/cells10082128.
31.
Hellmich B, Sanchez-Alamo B, Schirmer JH, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis 2024; 83: 30–47, DOI: 10.1136/ard-2022-223764.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.